Xperi Inc. (XPER)
(Delayed Data from NYSE)
$9.61 USD
-0.01 (-0.10%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $9.60 -0.01 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for Xperi Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 521 | 502 | 486 | 376 | NA |
Cost Of Goods | 119 | 123 | 126 | 78 | NA |
Gross Profit | 403 | 379 | 361 | 298 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 532 | 1,129 | 523 | 451 | 0 |
Income After Depreciation & Amortization | -130 | -749 | -162 | -153 | 0 |
Non-Operating Income | 0 | 2 | 2 | 2 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -130 | -748 | -160 | -151 | NA |
Income Taxes | 10 | 14 | 19 | -10 | NA |
Minority Interest | -3 | -4 | -3 | -3 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -140 | -761 | -179 | -141 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -137 | -757 | -176 | -138 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -55 | -62 | -34 | -38 | 0 |
Depreciation & Amortization (Cash Flow) | 74 | 687 | 128 | 115 | NA |
Income After Depreciation & Amortization | -130 | -749 | -162 | -153 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 43.01 | 42.03 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.61 | 0.80 | NA | NA | NA |
Diluted Net EPS (GAAP) | -3.18 | -18.02 | NA | NA | NA |
Fiscal Year end for Xperi Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 137.23 | 130.39 | 126.87 | 126.84 |
Cost Of Goods | NA | 33.57 | 26.41 | 30.86 | 27.79 |
Gross Profit | NA | 103.67 | 103.98 | 96.02 | 99.05 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 133.47 | 135.03 | 131.20 | 132.65 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -29.80 | -31.05 | -35.18 | -33.60 |
Non-Operating Income | NA | 0.05 | -1.34 | 0.91 | 0.37 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -29.75 | -32.39 | -34.27 | -33.23 |
Income Taxes | NA | -4.44 | 9.69 | 5.09 | -0.29 |
Minority Interest | NA | -0.52 | -0.65 | -0.97 | -0.94 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -25.31 | -42.07 | -39.36 | -32.94 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -24.79 | -41.43 | -38.40 | -32.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 43.72 | 43.32 | 42.77 | 42.22 |
Diluted EPS Before Non-Recurring Items | NA | -0.23 | -0.08 | -0.09 | -0.33 |
Diluted Net EPS (GAAP) | NA | -0.56 | -0.96 | -0.90 | -0.76 |